Drug Shortage Report for ETOPOSIDE INJECTION
| Report ID | 68626 |
| Drug Identification Number | 02080036 |
| Brand name | ETOPOSIDE INJECTION |
| Common or Proper name | ETOPOSIDE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ETOPOSIDE |
| Strength(s) | 20MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS |
| Packaging size | 10ML |
| ATC code | L01CB |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-12-04 |
| Estimated end date | 2020-03-31 |
| Actual end date | 2020-03-15 |
| Shortage status | Resolved |
| Updated date | 2020-03-16 |
| Company comments | Out of stock |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.